Skip to main content
Log in

Quantitative structure-activity relationships in MAO-inhibitory 2-phenylcyclopropylamines: Insights into the topography of MAO-A and MAO-B

  • Original Articles
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Ten (E)-and (Z)-isomers of 2-phenylcyclopropylamine (PCA), 1-Me-PCA, 2-Me-PCA, N-Me-PCA, and N, N-diMe-PCA and fifteeno , m, p isomers of (E)-PCA with substituents of Me, Cl, F, OMe, OH were synthesized in this laboratory and tested for the inhibition of rat brain mitochondrial MAO-A and MAO-B. The effects of substituents, their positions, and stereochemistry on the inhibition were assessed for the compounds with substituents at cyclopropyl and amino groups and QSAR analyses were performed using the potency data of ring-substituted compounds. The best correlated QSAR equations are as follows: pI50=0.804 Π2 Blo−1.069 Blm+0.334 Lp−1.709 HDp+7.897 (r=0.945, s=0.211, F=16.691, p=0.000) for the inhibition of MAO-A; pI50=1.815 π-0.825 Π2 R+0.900 Es2+0.869 Es3+0.796 Es4−0.992 HDp+0.562 HAo+3.893 (r=0.982, s=0.178, F=23.351, p=0.000) for the inhibition of MAO-B. Based on the potency difference between stereoisomers of cyclopropylamine-modified compounds and on QSAR results, it is proposed that the active sites of MAO-A are composed of one deep hydrophobic cavity near para position, two hydrophobic cavities interacting with Me group, a hydrophobic area accomodating phenyl and cyclopropyl backbone, steric boundaries, a hydrogen-acceptor site near para position, and an amino group binding site and that in addition to the same two hydrophobic cavities, hydrophobic area, steric boundaries, hydrogen-acceptor site, and amino group binding site, another steric boundary near para position and a hydrogen donating site near ortho position constitute active sites of MAO-B.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature Cited

  1. Johnston, J.P.: Some observations upon a new inhibitor of monoamine oxidase in brain tissue.Biochem. Pharmacol. 17, 1285 (1968).

    Article  PubMed  CAS  Google Scholar 

  2. Neff, N.H. and Yang, H.-Y.: Another look at the monoamine oxidases and the monoamine oxidase inhibitor.Life Sci. 14, 2061 (1974).

    Article  PubMed  CAS  Google Scholar 

  3. Green, A.L. and El Hait, M.A.S.:p-Methoxyamphetamine, a potent reversible inhibitor of type-A monoamine oxidasein vitro andin vivo.J. Pharm. Pharmacol. 32, 262 (1979).

    Google Scholar 

  4. Ask, A.-L., Högberg, K., Schmidt, L., Kiessling, H. and Ross, S.B.: (+)-4-Dimethylamino-2, α-dimethylphenethylamine (FLA 336 (+)), a selective inhibitor of the A form of monoamine oxidase in the rat brain.Biochem. Pharmacol. 31, 1401 (1982).

    Article  PubMed  CAS  Google Scholar 

  5. Ask, A.-L., Fagervall, L., Florvall, L., Ross, S.B. and Ytterborn, S.: Selective inhibition of monoamine oxidase byp-aminosubstituted phenylalkylamines in catecholaminergic neurones.Neuropharmacology. 25, 33 (1986).

    Article  PubMed  CAS  Google Scholar 

  6. Knoll, J. and Magyar, K.: Some puzzling pharmacological effects of monoamine oxidase in hibitors.Adv. Biochem. Psychopharmacol. 5, 393 (1972).

    PubMed  CAS  Google Scholar 

  7. Burger, A. and Yost, W.L.: Arylcycloalkylamines. I. 2-Phenylcyclopropylamine.J. Am. Chem. Soc. 70, 2198 (1948).

    Article  CAS  Google Scholar 

  8. Kaiser, C., Lester, B.M. and Zirkle, C.L.: 2-Substituted cyclopropylamines. I. derivatives and analogs of 2-phenylcyclopropylamine.J. Med. Pharm. Chem. 5, 1243 (1962).

    Article  CAS  Google Scholar 

  9. Zirkle, C.L., Kaiser, C., Tedeschi, D.H. and Tedeschi, R.E.: 2-Substituted cyclopropylamines. II. effect of structure upon monoamine oxidase-inhibitory activity as measuredin vivo by potentiation of tryptamine convulsions.J. Med. Pharm. Chem. 5, 1265 (1962).

    Article  CAS  Google Scholar 

  10. Fuller, R.W., Hernrick, S.K. and Mills, J.: Inhibition of monoamine oxidase by N-phenacyclcy clopropylamine.Biochem. Pharmacol. 27, 2255 (1978).

    Article  PubMed  CAS  Google Scholar 

  11. Fuller, R.W. and Hemrick, S.K.: Selectivein vivo inhibition of monoamine oxidase in rat tissues by N-[2-(o-chlorophenoxy)ethyl] cyclopropylamine (40197).Proc. Soc. Exp. Biol. Med. 158, 323 (1978).

    PubMed  CAS  Google Scholar 

  12. Fuller, R.W., Hemrick-Luecke, S.K. and Molloy, B.B.: N-[2-o-Iodophenoxy)ethyl] cyclopropylamine hydrochloride (LY 121768), a potent and selective irreversible inhibitor of type A monoamine oxidase.Biochem. Pharmacol. 32, 1243 (1983).

    Article  PubMed  CAS  Google Scholar 

  13. Kang, G.I., Hong, S.K. and Choi, H.K.: 1-Methyl substituent and stereochemical effects of 2-phenylcyclopropylamines on the inhibition of rat brain mitochondrial monoamine oxidase A and B.Arch. Pharm. Res. 10, 50 (1987).

    Article  CAS  Google Scholar 

  14. Kang, G.I. and Hong, S.K.: Synthesis of two nitro analogs of tranylcypromine: relations of aromatic substitution of nitro groups to MAO-inhibitory activity.Arch. Pharm. Res. 11, 33 (1988).

    Article  CAS  Google Scholar 

  15. Choi, M.H.: The effect of stereochemistry and methyl substitution at cyclopropyl and amino groups on the potency and selectivity of the inhibition of monoamine oxidase by 2-phenylcyclopropylamines.M. Sc. Thesis. Sookmyung Women's University (1988).

  16. Park, W.: Synthesis of methyl and chloro analogs of tranylcypromine: effects of aromatic substituents on MAO inhibitory properties.M. Sc. Thesis. Sookmyung Women's University (1989).

  17. Belleau, B. and Moran, J.: Deuterium isotope effects in relation to the chemical mechanism of monoamine oxidase.Ann. N.Y. Acad. Sci. 107, 822 (1963).

    Article  PubMed  CAS  Google Scholar 

  18. Silverman, R.B.: Mechanism of inactivation of monoamine oxidase bytrans-2-phenylcyclopropylamine and the structure of the enzymeinactivator adduct.J. Biol. Chem. 258, 14766 (1983).

    PubMed  CAS  Google Scholar 

  19. Kaiser, C., Burger, A., Zirngibl, L., Davis, C.S. and Zirkle, C.L.: N-Substituted derivatives of 2-phenylcyclopropylamines. Ring-opening reactions of 2-phenylcyclopropane derivatives.J. Org. Chem. 27, 768 (1962).

    Article  CAS  Google Scholar 

  20. Pine, S.H. and Sanchez, B.L.: The formic acid-formaldehyde methylation of amines.J. Org. Chem. 36, 829 (1971).

    Article  CAS  Google Scholar 

  21. Giumanini, A.G., Chiavari, G. and Scarponi, F.L.: N-Permethylation of polyamines for gas chromatographic and mass spectrometric analyses.Anal. Chem. 48, 484 (1976).

    Article  PubMed  CAS  Google Scholar 

  22. Loibner, H., Pruckner, A. and Stütz, A.: Reduktive Methylierung Primärer und Sekudärer Amine mit Hilfe von Formaldehyd und Salzen der Phosphorigen Säure.Tetrahedron Letters 25, 2535 (1984).

    Article  CAS  Google Scholar 

  23. Arvidsson, L.-E., Johansson, A.M., Hacksell, U., Nilsson, J.L.G., Svensson, K., Hjorth, S., Tagnusson, T., Carlsson, A., Lindberg, P., Andersson, B., Sanchez, D., Wikström, H. and Sundell, S.: N,N-Dialkylated monophenolictrans-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonists.J. Med. Chem. 31, 92 (1988).

    Article  PubMed  CAS  Google Scholar 

  24. Sjoerdsma, A., Smith, T.E., Stevenson, T.D. and Undenfriend, S.: Metabolism of 5-hydroxy-tryptamine (serotonin) by monoamine oxidase.Proc. Soc. Exptl. Biol. Med. 89, 36 (1955).

    CAS  Google Scholar 

  25. Udenfriend, S., Weissbach, H. and Clark, C.T.: The estimation of 5-hydroxytryptamine (serotonin) in biological tissues.J. Biol. Chem. 215, 337 (1955).

    PubMed  CAS  Google Scholar 

  26. Tabor, C.W., Tabor, H. and Rosenthal, S.M.: Purification of amine oxidase from beef plasma.J. Biol. Chem. 208, 645 (1954).

    PubMed  CAS  Google Scholar 

  27. Kang, G.I. and Choi, H.K.: Detection of N-acetyltranylcypromine and glucuronide of phen yl-hydroxylated N-acetyltranylcypromine from tranylcypromine-dosed rat urine: pharmacological implications.Arch. Pharm. Res. 9, 99 (1986).

    Article  CAS  Google Scholar 

  28. Unger, S.H.: Consequences of the Hansch paradigm for the pharmaceutical industry. inDrug Design, Vol. IX (Ariěns, E.J. ed.), Academic Press: New York, p. 47 (1980).

    Google Scholar 

  29. Tute, M.S.: Principles and practice of Hansch analysis: a guide to structure-activity correlation for the medicinal chemist.Adv. Drug Res. 6, 1 (1971).

    PubMed  CAS  Google Scholar 

  30. Chu, K.C.: The quantitative analysis of structure-activity relationships. inBurger's Medicinal Chemistry, Part 1, Fourth Edition (Wolff, M.E., ed.), John Wiley & Sons, New York, p. 393 (1980).

    Google Scholar 

  31. Verloop, A., Hoogenstraaten, W. and Tipker, J.: Development and application of new steric substituent parameters in drug design. inDrug Design, Vol. VII (Ariëns, E.J. ed.), Academic Press, New York, p. 165 (1979).

    Google Scholar 

  32. Martin, Y.C.: Advances in the methodology of quantitative drug design. inDrug Design, Vol. VIII (Ariëns, E.J. ed.), Academic Press, New York, p. 1 (1979).

    Google Scholar 

  33. Waley, S.G.: Kinetics of suicide substrates. Practical procedures for determining parameters.Biochem. J. 227, 843 (1985).

    PubMed  CAS  Google Scholar 

  34. Baker, G.B., Hampson, D.R., Coutts, R.T., Micetich, R.G., Hall, T.W. and Rao, T.S.: Detection and quantitation of a ringhydroxylated metabolite of the antidepressant drug Tranylcypromine.J. Neural Transmission.65, 233 (1986).

    Article  CAS  Google Scholar 

  35. Coutts, R.T., Rao, T.S., Baker, G.B., Micetich, R.G. and Eric Hall, T.W.: Neurochemical and neuropharmacological properties of 4-fluoro tranylcypromine.Cellular and Molecular Neurobiology.7, 271 (1987).

    Article  PubMed  CAS  Google Scholar 

  36. Kaiser, C. and Setler, P.E.: Antidepressant agents. inBurger's Medicinal Chemistry, Part III, Fourth Edition (Wolff, M.E. ed.), John Wiley & Sons, New York, p. 997 (1984).

    Google Scholar 

  37. Martin, Y.C., Martin, W.B. and Taylor, J.D.: Regression analysis of the relationships between physical properties and thein vitro inhibition of monoamine oxidase by propynylamines.J. Med. Chem. 18, 883 (1975).

    Article  PubMed  CAS  Google Scholar 

  38. Williams, C.H. and Lawson, J.: Monoamine oxidase-III. further studies of inhibition by propargylamines.Biochem. Pharmacol. 24, 1889 (1975).

    Article  PubMed  CAS  Google Scholar 

  39. Fujita, T.: Structure-activity relationships of monoamine oxidase inhibitors.J. Med. Chem. 16, 923 (1973).

    Article  PubMed  CAS  Google Scholar 

  40. Johnson, C.L.: Quantitative structure-activity studies on monoamine oxidase inhibitors.J. Med. Chem. 19, 600 (1976).

    Article  PubMed  CAS  Google Scholar 

  41. Williams, C.H.: Selective inhibitors of monamine oxidases A and B.Biochem. Pharmacol. 33, 334 (1984).

    Article  PubMed  CAS  Google Scholar 

  42. Schurr, A., Ho, B.T. and Schoolar, J.C.: Human brain monoamine oxidase: one molecular entity-multiple binding sites?J. Pharm. Pharmacol. 33, 165 (1981).

    PubMed  CAS  Google Scholar 

  43. Suzuki, O., Oya, M. and Katsumata, Y.: Oxidation ofp-, m- ando-tyramine by type A and type B monoamine oxidase.Biochem. Pharmacol. 28, 2682 (1979).

    Article  PubMed  CAS  Google Scholar 

  44. Tullman, R.H. and Hanzlik, R.P.: Inactivation of cytochrome p-450 and monoamine oxidase by cyclopropylamines.Drug. Metab. Rev. 15, 1163 (1984).

    Article  PubMed  CAS  Google Scholar 

  45. Riley, T.N. and Brier, G.G.: Absolute configuration of (+)-and (−)-trans-2-phenylcyclopropyl-amine hydrochloride.J. Med. Chem. 15, 1187 (1972).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kang, G.I., Hong, S.K. Quantitative structure-activity relationships in MAO-inhibitory 2-phenylcyclopropylamines: Insights into the topography of MAO-A and MAO-B. Arch. Pharm. Res. 13, 82–96 (1990). https://doi.org/10.1007/BF02857840

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02857840

Keywords

Navigation